Mr. Tony O'Brien:

There is a quality assurance committee with significant international representation in respect of the CervicalCheck programme that has reviewed programme data but has not raised flags of concerns about the fundamentals of the programme. As I said earlier, I think Deputy Cullinane was correct to identify and distinguish between the known shortcomings of all screening programmes which, unfortunately, will lead to a later diagnosis of cancer for patients who have not been detected in the screening programme, on the one hand, versus this failure to communicate in the aftermath of an audit process, which is really what this issue is actually about.